Observational studyThe Lancet. Microbe2025

Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial.

Meagan E Deming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.